The potential effectiveness of TQ offers a promising avenue as a protective agent against AD, contingent upon the upregulation of miR-9, which is linked to the inhibition of NF-κB and activation of PPAR-γ. The gene discussed is NFKB1; the disease is Alzheimer disease.